Literature DB >> 18701969

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study.

Johan Buffels1, Jan Degryse, Giuseppe Liistro.   

Abstract

STUDY
OBJECTIVES: To document the rate of diagnostic certainty, co-morbidity and use of medication in patients with presumed obstructive airway disease (OAD) in a primary care setting.
METHODS: Twenty-six general practitioners (GPs) were asked to select the last 50 contacts with patients older than 40 years of age who were taking bronchodilators and/or inhaled corticosteroids or who had known OAD. After reviewing their medical data on file, the GPs gave their diagnostic opinion and rated their certainty about the diagnosis using a Likert-type scale.
RESULTS: Analysis of 1126 files revealed that in at least 523 patients (46.4%), a diagnostic work-up was judged necessary. The GPs judged that 6% of the patients had no OAD. Less than 33% of the study population underwent spirometry during the two years preceding the survey. The number of co-morbid conditions was on average 2.2 for patients with asthma and 3.2 for patients with COPD. Patients with presumed COPD took significantly more drugs (mean, 5.1; 95% CI, 4.8-5.3) than did patients with other diagnostic labels (mean, 4.6 95%; CI, 4.4-4.8).
CONCLUSIONS: We confirmed the underuse of spirometry as a diagnostic tool in presumed airway obstruction in primary care. Nearly half of the patients older than 40 years who were taking bronchodilators and/or inhaled corticosteroids needed a diagnostic work-up. This population had a high prevalence of co-morbidity and polypharmacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18701969      PMCID: PMC6619038          DOI: 10.3132/pcrj.2008.00047

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  15 in total

1.  Nitric oxide measurement in chronic cough.

Authors:  Kaiser G Lim
Journal:  Lung       Date:  2009-10-07       Impact factor: 2.584

2.  Why is spirometry underused in the diagnosis of the breathless patient: a qualitative study.

Authors:  Nicola J Roberts; Susan F Smith; Martyn R Partridge
Journal:  BMC Pulm Med       Date:  2011-06-16       Impact factor: 3.317

3.  Standards of suitability for the management of chronic obstructive respiratory diseases.

Authors:  Claudio M Sanguinetti; Nicolino Ambrosino; Filippo Andò; Fernando De Benedetto; Claudio F Donner; Stefano Nardini; Mario Polverino; Roberto Torchio; Guido Vagheggini; Alberto Visconti
Journal:  Multidiscip Respir Med       Date:  2014-12-18

4.  Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study.

Authors:  Marietta Rottenkolber; Eef Voogd; Liset van Dijk; Paola Primatesta; Claudia Becker; Raymond Schlienger; Mark C H de Groot; Yolanda Alvarez; Julie Durand; Jim Slattery; Ana Afonso; Gema Requena; Miguel Gil; Arturo Alvarez; Ulrik Hesse; Roman Gerlach; Joerg Hasford; Rainald Fischer; Olaf H Klungel; Sven Schmiedl
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Co-morbidities in 99 COPD patients: A case series from Syria.

Authors:  Yousser Mohammad; Fatima Yassine; Mais Khadouj
Journal:  J Transl Int Med       Date:  2015-12-30

6.  Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study.

Authors:  Luis García-Olmos; Angel Alberquilla; Victoria Ayala; Pilar García-Sagredo; Leticia Morales; Montserrat Carmona; María José de Tena-Dávila; Mario Pascual; Adolfo Muñoz; Carlos H Salvador; Jose L Monteagudo
Journal:  BMC Fam Pract       Date:  2013-01-16       Impact factor: 2.497

7.  COPD management in primary care: is an educational plan for GPs useful?

Authors:  Enrica Bertella; Alessandro Zadra; Michele Vitacca
Journal:  Multidiscip Respir Med       Date:  2013-03-19

8.  General practice variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease in Denmark: a population-based observational study.

Authors:  Mette M Koefoed; Jens Søndergaard; René dePont Christensen; Dorte E Jarbøl
Journal:  BMC Fam Pract       Date:  2013-08-07       Impact factor: 2.497

9.  Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study.

Authors:  Nicolas Roche; Céline Pribil; Eric Van Ganse; Philippe Serrier; Bruno Housset; Déborah Poirier; Nathalie Texier; Stéphane Schück; Isabelle Boucot
Journal:  BMC Pulm Med       Date:  2014-04-02       Impact factor: 3.317

10.  Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education.

Authors:  Claudio M Sanguinetti; Fernando De Benedetto; Claudio F Donner; Stefano Nardini; Alberto Visconti
Journal:  Multidiscip Respir Med       Date:  2014-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.